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Abstract 
 
Introduction: Legionnaires’ is a severe pneumonia, the diagnosis of which 
can be confirmed by a positive Legionella Urinary Antigen (LUA) test. The 
British Thoracic Society has specific guidelines for its use. Incorrect LUA test 
requests can result in false-positive results while accumulating costs.  
Aims and Objectives: The aim is the rationalisation of LUA testing. The first 
objective is to educate clinicians on indications for testing reducing 
unnecessary orders. The second is to develop a laboratory Standard 
Operating Procedure (SOP) to screen test requests. The third is to reduce 
costs. Methodology: Rationalisation of laboratory testing can be through 
clinical education, laboratory administrative methods or a combination. The 
HSE Model guided the change process. A pre-change audit created urgency, 
engaged key stakeholders and informed development of the SOP. Face-to-
face education was undertaken in H1 & H3, with a written memo distributed to 
H2. The new SOP was presented to laboratory staff. Post-change audit 
results were used to mainstream. Evaluation: Following change 
implementation there was a decrease in LUA test requests in H1 & H3 of 
17.5% and 15% respectively, but an increase of 2.3% overall. The total 
reduction in tests processed was 71.5% reducing costs by €2,195.52 and 
saving 24 hours of laboratory time. Conclusion and Organisational Impact: 
Face-to-face educational interventions are beneficial however administrative 
methods are most effective when rationalising laboratory test usage. High-
level management support and early engagement of stakeholders is key in 
successful change. Once mainstreamed, a saving of €28,541 and 312 
laboratory hours per annum is predicted.  
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1.0 Introduction    
1.1 Introduction 
 
Change is a requirement of organisations across all sectors, healthcare 
included. Changes are constantly occurring in healthcare in Ireland, some 
large, such as the launch of the National Clinical Care Programmes in 2010, 
others small, such as the introduction of a local programme encouraging hand 
washing. Not every change project is successful, in fact often most reportedly 
fail (Burnes, 2004a; Ford & Ford, 2010; Higgs & Rowland, 2005; Sirkin et al., 
2005) but most changes likely fall on a spectrum between success and failure. 
NICE recognise that even modest changes can have significant positive 
patient impact (National Institute for Health and Clinical Excellence, 2007).  
 
The quality of healthcare can be improved by a wide range of interventions 
bettering professional practice and patient care (Oxman, Thomson, Davis, & 
Haynes, 1995). In any large organisation such as the Health Service 
Executive (HSE), any number of these interventions, quality improvement 
projects or changes will be occurring simultaneously (Cutcher-Gershenfeld, 
Ernst Kossek, & Sandling, 1998) and are all hopefully toward the shared 
vision of the HSE, to “enable people lead healthier and more fulfilled lives” 
(Drumm, 2008). 
 
This thesis will describe the rationalisation of Legionella Urinary Antigen 
(LUA) testing in four hospitals. In this introductory chapter key concepts will 
be introduced and the nature and context of the change will be discussed. 
Chapter 2 evidences the rationale for change through a literature review. A 
description of the change will follow in the Methods Chapter. In Chapter 4, an 
evaluation of the results will be presented. The final chapter will be used to 
critically discuss key findings of the change implementation, results and 
outcomes as well as provide a commentary on the key concepts as well as 
make recommendations going forward.  
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1.2 Rationale for Change 
 
Legionnaires’ disease is a rare condition with an average of 13 cases reported 
in Ireland per annum (European Centre for Disease Prevention and Control, 
2012). In 2012, 1,270 LUA tests were processed in the laboratory in question. 
Given the test is not 100% sensitive; processing tests without indication 
increases the incidence of false-positive results (van Walraven & Naylor, 
1998). False-positive results negatively impact patient care through exposure 
to unnecessary antimicrobials or a delayed diagnosis. A further reason to 
rationalise testing is that unnecessary processing is expensive, as the direct 
costs of reagents and laboratory scientist time rapidly accumulate (Kwok & 
Jones, 2005; van Walraven & Naylor, 1998).  
 
Guidelines exist for the indications for Legionnaires’ testing, in the form of the 
British Thoracic Society (BTS) Guidelines entitled “Management of 
Community Acquired Pneumonia in Adults” (Lim et al., 2009), Appendix 1. 
These internationally recognised guidelines are advocated by the clinical 
microbiology team and form part of the local antimicrobial guidelines, 
Appendix 2. It was hypothesised that use of the LUA test was often outside 
the guidelines prior to this change management project and this was proven in 
the pre-change audit.  
 
1.3 Nature and Context of the Change 
 
Currently the laboratory processes each LUA request if correctly labeled. This 
initiative will reduce the number of LUA tests processed by both reducing the 
numbers of test requested through education and increasing guideline 
compliance, as well as enabling laboratory scientists to screen specimens 
based on the clinical data provided.  
 
For a project to be successful, the change must be assessed on both merit 
and overall place within the organisational context (Higgs & Rowland, 2010; 
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Michel, By, & Burnes, 2013). The HSE National Service Plan 2014 states, 
“while budgets are being reduced… we are aiming… to maximise efficiencies 
and ensure that we maintain sustainable levels of service with quality and 
patient care at the heart of everything we do”. This objective is similar to the 
mission statement of the change agents’ organisation; “[to] provide quality 
patient care, delivered by skilled and valued staff, through the best use of 
available resources” (Health Service Executive, 2014). This project fits with 
local and national ideals by looking to improve the quality of service provision 
while meeting cost parameters.   
 
The population served by the four acute hospitals and laboratory is 
approximately 500,000, and 1,160 hospital beds. There are three Consultant 
Clinical Microbiologists and two Clinical Microbiology Specialist Registrars 
(SpRs) based in the largest hospital (herein referred to as H1). The two SpRs 
cover the other three hospitals remotely daily and one consultant spends one 
day per week in one of the other three hospitals. There are approximately 
forty microbiology laboratory scientists working in the department, and the 
laboratory processes approximately 300,000 specimens per annum. This 
figure increases year on year without an increase in funding or staffing.  
 
The Chief Scientist is a proactive well-respected leader. Together with the 
clinical microbiology team the laboratory remains at the cutting edge of 
Clinical Microbiology by embracing change. This is the first laboratory to 
introduce the LUA test. As a whole, the department presents regularly at local, 
national and international meetings such as the regional quality conference, or 
the Irish Society of Clinical Microbiology meeting. This demonstrates the 
culture of change and quality improvement within the department. Literature 
demonstrates that a culture of change (Gill, 2011) as well as a readiness for 
change (Armenakis & Harris, 2002; Palmer, 2004; Smith, 2005) increases the 
likelihood of successful endeavours.  
 
Interdisciplinary engagement between the clinical microbiologists and the 
laboratory scientist staff is promoted as evidenced by collaborative research 
from the department. Multi-disciplinary term engagement improves the quality 
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and service delivery in healthcare (Borrill, West, Shapiro, & Rees, 1999; 
Tanco, Jaca, Viles, Mateo, & Santos, 2011).  
1.5 Leader of the Change 
 
The change agent is a Clinical Microbiology SpR in H1 and commenced in 
this role shortly prior to the start of this project. Although leading in this 
change management project, the change agent has no formal authority over 
any stakeholder groups, and as a new staff member had little influence in the 
beginning. 
 
Leadership in an economic crisis is critical, but what leadership style is best? 
Clinicians and healthcare managers need to adapt in response to the external 
environment, which at present is economic turmoil. The tenuous balance 
between quality and cost must be achieved and value-based leadership 
models, or transformational leadership (Mills & Spencer, 2005) may be the 
means. Authentic leadership fits with the concept of transformational; those 
leaders who raise people’s motivation and sense of higher purpose (Gill, 
2011). The call for authentic leaders, or those who are seen to be value-
based, has arisen from public fatigue of leaders who fall from grace (Gill, 
2011).  
 
Distant leadership is an emerging reality (Hay Group, 2011). With the 
formation of hospital groups and pending independent hospital trusts, remote 
leadership skills will be required (Department of Health, 2013). In the current 
structure of the Clinical Microbiology Department, H2, 3 and 4 are managed 
remotely. Lessons in distant leadership are mainly from industry, but 
transformational leadership is possible (Gibson & Manuel, 2003; Holtbrügge, 
Schillo, Rogers, & Friedmann, 2011). Mastering successful communication is 
a challenge but must be overcome to avoid misunderstandings and loss of 
commitment (Gibson & Manuel, 2003; Kayworth & Leidner, 2000). Face-to-
face engagement with clinicians increases guideline compliance and changes 
practice more than written interventions alone (O’Brien et al., 2007; Soumerai 
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et al., 1993), however a key issue arising in this project was how to implement 
a change across four sites without a personal interaction.  
 
Increasingly frequently in healthcare it is realised that changes and quality 
improvements often come from front-line staff, not necessarily those in 
managerial roles (Fleming, Lynch, Heslin, & Ryan, 2008; NHS Leadership 
Academy, 2011; The King’s Fund, 2011). These emergent leaders, are borne 
from a situational need (Karp & Helgø, 2008). Furthermore clinical 
engagement is a powerful tool in service development and improvement (Ham 
& Dickinson, 2008; “Medical Engagement Scale,” n.d.). Clinicians dictate 
where budgets as they order tests (Friedman & Katt, 1991; van Walraven & 
Naylor, 1998; Yeh, 2014) and treat the patients. Clinician and management 
engagement can control service costs (Ham & Dickinson, 2008; Tanco et al., 
2011) and clinical and laboratory specialists collaborating can reduce 
laboratory costs (Baron et al., 2013).  
 
In summary, the change agent is new member of staff, introducing a change 
across four locations with no formal authority over any of the stakeholder 
groups. The change agent is a clinician as well as a laboratory specialist and 
hopes to bridge the gaps between clinical medicine, laboratory medicine and 
the laboratory sciences. It is hoped that implementation of this change will 
teach the change agent core skills to lead change again (Quinn, 2011).  
 
1.6 Aims and Objectives 
 
Aim  
 
The aim of this change management project is the rationalisation of Legionella 
Urinary Antigen testing within the organisation. The primary objectives are: 
• Undertake a pre-change audit to investigate if LUA tests requests are 
indicated when audited against best practice as well as ascertain 
compliance with the pre-change Standard Operating Procedure (SOP) 
by laboratory staff 
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• Education of clinicians on the appropriate use of the LUA test to reduce 
orders  
• Development of a laboratory intervention to reduce the processing of 
tests that are likely not indicated 
• Reduce costs by rationalising use of the LUA test 
• Undertake a post-change audit of clinical and laboratory practice. 
 
1.7 Conclusion 
 
In conclusion, this is a change management project to rationalise LUA testing 
across four hospitals. In the next chapter, the evidence supporting 
undertaking will be discussed, as well as a review of the literature pertaining 
to the available interventions to rationalise laboratory testing.  
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2.0 Literature Review 
 
 
2.1 Introduction 
 
Community acquired pneumonia (CAP) is a leading cause of hospital 
admissions, and a major cause of morbidity and mortality worldwide (Lim et 
al., 2009). Legionella species are an uncommon cause of CAP with the total 
number of cases per year in Ireland ranging between 7 and 14 (European 
Centre for Disease Prevention and Control, 2012). Legionnaires’ disease 
requires the diagnosis of pneumonia with microbiological confirmation. A 
Legionella Urinary Antigen test is one such method.  
 
The aims of this literature review have been to discuss diagnostic methods of 
Legionnaires’ and critically appraise the LUA test as a diagnostic tool.  This 
will be followed by an appraisal of the literature pertaining to changing the 
clinical practice of physicians, particularly in the context of adherence to 
guidelines, local, national or international. Finally, a focused discussion on 
how to rationalise test requests will follow. The relevant information gathered 
will be extrapolated and discussed in the organisational context.  
 
2.2 Search Strategy 
 
For this literature review, Pubmed was searched using the search terms  
(Legionella OR legionnaires’) AND antigens, bacterial/urine[MeSH 
Terms](medical subject heading) and the filters “English language” and 
“humans”. This resulted in 124 results on 04/12/13. The author also used a 
similar search strategy in the Cochrane library, MEDLINE and CINAHL plus. 
Articles were selected by relevance to this topic. This database search was 
then supplemented with selecting references as utilised by key papers. In 
total, 28 references were utilised.  
 
A further search using paired MeSH (medical subject heading) terms “cost 
effectiveness analysis” and “laboratories, hospital/utilization”, yielded 124 
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results on 19/12/13, reduced to 55 with the use of the filters “English 
language” and “humans”. Using the key words and phrases, “utilization”, 
“laboratory” and “improve”, CINAHL Plus was searched on 19/12/13, yielding 
39. Similar search techniques were applied in MEDLINE and the references of 
key papers were also utilised. 
 
The final search was undertaken using “clinician” “compliance” and “guideline” 
in Emerald insight on 6/3/14 yielding 25 journal results. A similar search in the 
Wiley library on the same date using the search terms “guideline compliance”, 
“clinical practice” and “improve” in all fields yielded 243 journal articles. The 
references of key papers were also utilised.  
 
2.3 Evidence for change 
 
2.3.1 Diagnosis of Legionnaires’ disease  
 
Legionnaires’ disease is a severe pneumonia, often requiring hospital 
admission. It is difficult either clinically or radiologically to distinguish it from 
more common causes of pneumonia, such as Streptococcus pneumoniae 
(Mandell et al., 2009; Tan, 2000). There are clinical features, risk factors and 
biochemical abnormalities that make a diagnosis of Legionnaires’ more likely 
but are not highly specific (Birkin, Biyani, & Browning, 2011; Mandell et al., 
2009).  
 
There are a number of methods by which to confirm a diagnosis of 
Legionnaires’ disease. The detection of Legionella pneumophilia in specimens 
using immunoflourescent microscopy is one method however requires 
specialist equipment and expertise and is insensitive (Mandell et al., 2009). 
Legionella species could be cultured from clinical specimens, but again 
requires both specialised media and expertise not be available in all standard 
laboratories and can take up to fourteen days (Health Protection Surveillance 
Centre, 2009; Mandell et al., 2009). Antibody detection in serology samples is 
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specific for Legionnaires’ however requires two blood tests at least four weeks 
apart therefore not clinically useful (Mandell et al., 2009).  
 
The widespread availability of urine antigen tests has revolutionised the 
laboratory diagnosis of Legionnaires’. These are immunochromatographic 
membrane assays that detect Legionella pneumophila serogroup 1 antigen in 
urine. Legionella pneumophilia serogroup 1 causes 85-90% of human 
infections (Mandell et al., 2009; Tijet et al., 2010; Yu et al., 2002). These tests 
are widely available and give a result within minutes, however are not perfect, 
as will be discussed.  
 
2.3.2 Legionella Urinary Antigen Test: Role in Diagnostics 
 
The manufacturer of the LUA test reports both the sensitivity and specificity as 
95% (Alere, n.d.). However, a large meta-analysis of commercially available 
LUA tests suggested that early publications on sensitivity and specificity may 
have over-estimated test performance (Shimada et al., 2009). It is now more 
likely that a positive LUA test, when used in the appropriate clinical setting, 
diagnoses up to 74% of Legionnaires’ cases (Shimada et al., 2009). This is 
partially because the tests picks up Legionella pneumophila serogroup 1 only 
leading to under-diagnosis (File, 2003).  
 
As the LUA test has a high sensitivity but a lower specificity than previously 
indicated (Shimada et al., 2009) it is a test that should be used to confirm, 
rather than exclude, Legionnaires’. As with most tests, false positives can 
occur and have been reported in the literature (Bailleul, 2004; Deforges et al., 
1999), in some reports as high as 2.9% (Helbig et al., 2001). This encourages 
the use of the LUA only when indicated to reduce the risk of false-positive 
results occurring.  
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2.3.3 Potential benefits and pitfalls of Legionella Urinary Antigen Testing  
 
There are obvious advantages to using the LUA test. Early diagnosis and 
treatment improve patient morbidity and mortality as well as lead to early 
recognition of Legionnaires' outbreaks (Alvarez et al., 2009). To ensure the 
diagnosis is not missed, most guidelines empirically cover for Legionella 
infection in a severe pneumonia or if risks for Legionnaires’ exist (Lim et al., 
2009).  
 
The British Thoracic Society (BTS) updated their guidelines on the 
investigation and management of CAP in 2009 (Lim et al., 2009). Largely 
respiratory physicians devise these evidence-based guidelines. They stratify 
pneumonia into mild, moderate and severe using the CURB-65 score1 and 
advise microbiological investigations and antibiotic treatment accordingly, 
Appendix 1. These guidelines recommend that only a severe pneumonia, or a 
moderate pneumonia with risks for Legionnaires’ should be tested with an 
LUA. There are exceptions to these guidelines, such as that the CURB-65 
score has not been validated for immunocompromised patients or in those 
under the age of 30 (Health Protection Agency, 2012).  
 
These guidelines although widely accepted throughout the UK and Ireland are 
not without critics. Wingfield et al published a study demonstrating that on 
review of hospital admissions CAP, 25% of cases of Legionnaires’ would have 
gone undiagnosed if these guidelines are (Wingfield et al., 2013). However it 
has been demonstrated that routine testing for Legionnaires’ is unlikely to be 
cost effective (Murdoch et al., 2013) as guidelines empirically treat 
Legionnaires’ in moderate to severe cases.  
 
In the past if Legionnaires’ is out-ruled by a negative LUA test, atypical 
antimicrobial cover was discontinued (Roger et al., 2010). More recent studies 
have expressed concerns on narrowing therapy, due to a higher risk of clinical 
                                                        1 CURB‐65 score: One point for each of Confusion, Urea >7 mmol/L, Respiratory rate >30/min, Systolic blood pressure <90 mmHg and/or Diastolic blood pressure <60 mmHg and Age >65 years 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relapse (Falguera et al., 2010). Possible reasons for this relapse would be: 
failure to treat other serogroups of Legionella species not detected by the test 
(Mandell et al., 2009), the low specificity of the LUA test (Shimada et al., 
2009), infection caused by other difficult pathogens to identify (Houck, 2001) 
such as Mycoplasma pneumoniae, or the presence of a mixed infections 
(Roig et al., 2003).  
 
There has been increasing evidence in recent years that focused treatment 
for Legionnaires’ with a fluroquinolone, which is not first line in most 
guidelines, improves outcomes (Bartlett, 2008). Fluroquinolones may hasten 
recovery (Blázquez Garrido et al., 2005; Griffin et al., 2010; Haranaga et al., 
2007) and reduce hospital admission times (Mykietiuk et al., 2005; Sabrià et 
al., 2005) likely reducing hospital costs.  
 
If Legionnaires’ is rare, empirically covered in empiric guidelines and the LUA 
test is not highly specific and sensitive, is there a benefit to the laboratory 
providing the test? If antimicrobial therapy is not going to be adjusted with a 
negative test is there a value in its performance? What is the benefit to 
knowing the pathogen (Mandell, 2010)? The author finds that as the evidence 
suggests that focused treatment improves patient outcomes, and as the 
diagnosis is important from a public health viewpoint, it is reasonable to test 
using a LUA test but rationalise how and when it is used, thus providing the 
rationale for undertaking this project. 
 
2.3.4 Increasing guideline compliance by clinicians to change ordering 
behaviour  
 
Evidence-based medicine and best-practice guidelines aim to improve 
healthcare and service delivery (Audet, 1990; Chassin, 1990). Clinical 
guidelines are “systematically developed statements to assist practitioner[s]… 
about appropriate health care for specific… circumstances” (Field & Lohr, 
1990). They aim to improve clinical outcomes by limiting deviation from 
proven effective practices (Audet, 1990; Cabana et al., 1999). Although 
guidelines may be introduced in a hospital, their success is wholly dependent 
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on their adoption into practice, which is difficult to obtain (Cabana et al., 
1999).  
 
Guideline adherence is likely to be increased if the guideline, such as the BTS 
guideline, is advocated by a recognised body and supported by local 
authorities (Dawson et al., 1999). The guideline used at the core of this 
change project is an “external” guideline, i.e. developed by an external body, 
but promoted by clinical microbiology and respiratory physicians, therefore is 
also an internal guideline (Grimshaw & Russell, 1994), Appendix 1&2.  
 
Successful introduction of a guideline into practice requires all the principles 
of change management such as strong leadership and amplified 
communication (Grimshaw & Russell, 1994). There are often barriers 
impeding the adoption of guidelines into practice. The clinician may not agree 
with the guideline or be aware of its existence. There may be a cultural inertia 
surrounding change within that organisation (Cabana et al., 1999). 
Organisational barriers exist and hurdles such as staff turn-over make long 
term compliance with guidelines difficult to maintain (Brand et al., 2005). Prior 
to the introduction of a guideline, these barriers must be addressed (Brand et 
al., 2005; Cabana et al., 1999).  
 
Face-to-face education can change the practice of clinicians and increase 
guideline compliance (O’Brien et al., 2007). The “social marketing approach” 
is where face-to-face interactions focus on identifying barriers to change, 
developing shared objectives by encouraging physician contribution and 
engage opinion leaders (O’Brien et al., 2007; Soumerai et al., 1993). Many of 
these concepts are similar to the principles of the HSE Change Model 
(Fleming et al., 2008).  Distribution of hard copies of educational materials 
only has a small effect on guideline compliance (Giguère et al., 2012), 
however combined with another intervention can be beneficial.  
 
Improvements in clinical practice and guideline adherence can be obtained 
through audit and feedback (Jamtvedt et al., 2006; Mandelblatt & Kanetsky, 
1995). These interventions, combined with face-to-face educational visits can 
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accumulate to positively improve the targeted clinical practice (Soumerai et 
al., 1993). Engaging opinion leaders to communicate a message can improve 
guideline compliance (Flodgren et al., 2011) and multi-faceted approaches 
have the most promising data (Prior et al., 2008).  
 
The BTS have a guideline recommending when a LUA test should be 
ordered. The first change is to encourage clinicians to comply with this 
international guideline locally promoted. The second change is then to enable 
the laboratory to screen requests to see if they are in accordance with this 
guideline.  
 
2.3.5 Rationalisation of test requests 
 
Rationalisation of laboratory testing is a complex process. There is a balance 
between the need to curtail escalating costs of investigations without 
negatively impacting on patient care (Friedman & Katt, 1991). Changing 
clinician-ordering practices can be challenging. Interventions can be classified 
as administrative or educational (Calderon-Margalit et al., 2005). 
Administrative methods include restricting certain tests outside “normal” 
working hours, restricting duplication of tests or holding likely unnecessary 
tests pending clinical details. These restrictive methods can have negative 
consequences risking a delayed diagnosis thus adversely affecting patient 
care (Cherry, 2005). Senior management must acknowledge this risk prior to 
implementation. 
 
Education is the second type of intervention which can be utilised and can be 
verbal or written (Calderon-Margalit et al., 2005). Many educational 
interventions use audit as a tool or feedback mechanism. Bareford and 
Hayling demonstrated substantial improvements in laboratory ordering by 
clinicians through the use of positive feedback, such as publicising the overall 
reduction in ordering on a monthly basis etc (Bareford & Hayling, 1990).  
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Strategies that focus on changing practice through one intervention only may 
have a limited impact. Combined administrative and educational interventions 
are more likely to be successful (Marton, 1985; Smellie, 2012; Solomon, 
1998). Assessing the baseline use of a test, implementing a guideline then re-
auditing has been shown as an effective means of changing clinician ordering 
behaviour (Nardella, Farrell, Pechet, & Snyder, 1994; Yeh, 2014) and has 
influenced the direction of this change project. Dowling et al. undertook a 
baseline audit of test utilisation, fed-back results to clinicians once then re-
audited for a third time and demonstrated that once the second audit had 
finished, test ordering drifted back to the level of before the intervention 
(Dowling, 1988). This shows that without repeating audits including feeding 
the change may fail long-term (Fleming et al., 2008). 
 
Following interventions to change ordering, the results can be variable. Some 
report the outcome was less than 50% of desired (O’Brien et al., 2007). 
Others such as Grimshaw et al., demonstrated that a dual pronged approach 
of education coupled with a laboratory intervention could reduce processing 
by 50% (Grimshaw & Russell, 1994). Repeatedly stated as a critical success 
factor is the need for senior management support and engagement (Bareford 
& Hayling, 1990; Dowling, 1988; Yeh, 2014). Also, organisational barriers 
(Brand et al., 2005), such as frequent staff turnover, need to be addressed 
early in the process (Dowling, 1988). A positive approach to auditing, 
education and feedback is more likely to lead to a long-lasting change 
(Bareford & Hayling, 1990). Unless these factors occur, changes will be 
difficult to achieve and maintain (Axt-Adam et al., 1993).  
 
An important question to be asked is why are clinicians over-ordering tests? 
There are many feasible answers, including lack of awareness of a guideline 
(Cabana et al., 1999) or fear of missing a diagnosis (Yeh, 2014).  
Collaboration between clinicians and laboratory specialists can reduce 
unnecessary testing (Baron et al., 2013; Wu, 1998) ensuring that laboratory 
resources are used more appropriately (Kwok & Jones, 2005; Nightingale, 
Peters, Mutimer, & Neuberger, 1994). 
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2.4 Conclusion 
 
The scope of this chapter has been broad. CAP is a leading cause of hospital 
admissions; of which Legionnaires’ is a rare but important cause. A discussion 
on the difficulties in the diagnosis of Legionnaires’ has demonstrated that a 
LUA test is currently the best available, and that although its sensitivity and 
specificity are less than ideal, it has a role in practice. Confirmation of 
Legionnaires’ allows a patient to be switched to a more effective therapy and 
alerts Public Health officials to a possible epidemiological source. Given the 
low specificity of the test, it should be undertaken only when there is a clear 
clinical indication to avoid a false positive result. This is also a cost-effective 
approach to testing. 
 
Changing clinical practice to adhere to a guideline can be challenging. It is 
likely that education, the use of opinion leaders as well as audit and feedback 
will be a combination more likely to lead to long lasting change. The main 
tools used to rationalising tests requests can be administrative or educational. 
It is likely that a combination of these tools will be most successful. Alanzo et 
al., suggest that clinical behaviour can be modified using education, 
motivation and facilitation, all of which are targeted in both the HSE Change 
Model and then in this project (Alvanzo, Cohen, & Nettleman, 2003; Fleming 
et al., 2008). 
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3.0 Methodology 
 
 
3.1 Introduction 
 
In this chapter, the author will critically discuss three change models that are 
acclaimed in the literature, followed by a more detailed discussion on the 
model chosen for this thesis. Then the practical application of that change 
model translated into practice will be described.  
 
There is a continual clash between change theory and the practicalities of its 
implementation. Often it is found that models with a sound theoretical basis 
may not apply in reality (Burnes, 2004c; McAuliffe & Vaerenbergh, 2006; 
Young, 2011). Numerous models have been developed to guide 
organisational change, which in itself suggests that there is no superior model 
accepted by all. Taking strengths from a combination of theories to use in 
one’s own organisation may be an effective approach to change (Sidorko, 
2008).  
 
3.2 Discussion of Change Models 
 
3.2.1 Young’s Meta-Model For Change 
 
Young’s Model is formulated by weaving strands from various perspectives on 
change, e.g. individual verses organisational change, giving a rounded view 
grounded on a broad literature base. This comprehensive model looks at nine 
different stages, Appendix 4, many of which are common to other models, for 
example the “commitment to act” is similar to the “building commitment” stage 
of the HSE Change Model (Fleming et al., 2008; Young, 2009). It also draws 
in part from the Deming Cycle, acknowledging the need to “do-check-act” 
(Deming, 1982) similar to the “Plan-Do-Study-Act” quality improvement tool 
(Langley et al., 2009). This tool steers the direction of the change as it occurs 
(Young, 2009). It also indicates to followers that there has been a 
  17 
demonstrable transformation, voicing the “short-term wins” as lauded by 
Kotter (Kotter, 1995).   
 
Young’s Meta-Model was not chosen for this thesis as some stages have little 
relevance to this undertaking. For example, the behavioural “pre-change 
paradigm” (Young, 2009) component is not applicable to this project. Young 
hopes that by continually obtaining feedback from service users, areas for 
improvement will be identified early, avoiding change as a reaction to a 
“crisis”. The need for rationalisation of LUA testing change was previously 
identified as an area for improvement and placed on the laboratory 
management agenda. However it was not tackled until an increase in false-
positive results pushed it to the fore, more as a reactive change then a 
planned event. 
 
Young implies that the role of the leader is to provide the vision without 
“micro-managing “ issues (Young, 2009). His approach to change is a top-
down approach where the change agent has the authority to direct and 
delegate where appropriate. Firstly, the author does not have direct authority 
over any stakeholders. Secondly, this dissertation is an action-based 
organisational development project where the change agent experiences and 
learns from leading a change. Finally, in healthcare there has been a move to 
clinical engagement in a shared leadership model replacing a hierarchical top-
down approach to management.   
 
3.2.2 Kotter’s Change Model 
 
Kotter’s Change Model gives a map of change that is unidirectional 
suggesting steps should be followed sequentially, Appendix 5 (Kotter, 1996). 
Unlike Young’s approach he does not suggest that adjustments need to be 
made while the change is ongoing. He approaches change as a single event 
that is going to happen in isolation and once initiated continues until 
completion. Healthcare is a notoriously dynamic environment where long 
term-planning is difficult and an adaptive approach to change is crucial 
  18 
(Koeck, 1998). Many organisations, healthcare included, experience both 
planned and emergent change on a near daily basis (McAuliffe & 
Vaerenbergh, 2006). Kotter’s Model lacks the audit and re-audit cycles that 
are seen in Young’s Model and others, to allow for adaptation in a complex 
environment.  
 
Kotter’s Model discusses how to overcome resistance and obstacles 
encountered when leading change (Kotter, 1995). Similar to Young, he 
favours a “command-and-control” approach to leadership (Argyris, 1999). He 
provides little information on the practicalities of change, such as the 
previously discussed value of auditing during changes or of useful tools such 
as a stakeholder analysis.  
 
Kotter’s Model, although famously known for eight steps, can be sub-
categorised into three: preparation, action and grounding. Compared to the 
HSE Model, it lacks the initiation stage. It is in this stage that crucial 
information is gathered prior to commencement. Kotter however, begins his 
model establishing a sense of urgency for change without discussing the 
feasibility of its implementation. The HSE Model and Young promote the 
thorough research of any change project prior to its commencement, including 
consideration of possible alternatives (Fleming et al., 2008; Young, 2009) to 
reduce the risk of failure.  
 
3.2.3 HSE Change Model 
 
There are numerous reasons for choosing the HSE Change Model. This 
framework was designed specifically for use in the Health Service Executive 
(HSE), where this project occurs. It was created from other change models 
then adapted to suit a healthcare environment (Fleming et al., 2008). One of 
the key aims in its development was to encourage a “consistent approach to 
change across the system” (Fleming et al., 2008). 
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The HSE Change Model should have a certain amount of familiarity and 
credibility amongst HSE staff. If stakeholders are not familiar with the model 
itself per se, the language and terminology are easily understood.  Designed 
to be accessible to users, it does not require any prior theoretical 
management knowledge. It is a step-by-step guide with sufficient detail and 
supplementary materials to direct a relatively in-experienced change leader 
(Fleming et al., 2008).  
 
The initial step of the HSE Model is phrased “preparing to lead the change”. 
This phrasing puts the change agent at the centre of the project. This 
statement stresses the importance of the change agent and gives ownership 
to them from the beginning. Ownership and accountability continually emerge 
as themes throughout the HSE Change Model (Fleming et al., 2008) and 
throughout change literature in general (Bartkus, 1997; Gill, 2011; NHS 
Leadership Academy, 2011; Prime Minister’s Strategy Unit, 2004; Strebel, 
1996; Young, 2009).  
 
The importance of gaining commitment and preparing for change has been 
lauded in the literature (Burnes, 2004c; Fleming et al., 2008; Kotter, 1995; 
Sirkin et al., 2005). The HSE Change Model recognises the importance of 
these stages, allowing four of the seven steps to focus the change agent on 
rallying support. The support of high-level management and use of opinion 
leaders is stressed as key by both Fleming and Kotter (Fleming et al., 2008; 
Kotter, 1996) and also emerged as a critical success factor from the literature 
review on changing clinical practice (Bareford & Hayling, 1990; Dowling, 
1988; Yeh, 2014).  
 
The HSE Change Model uses the theories of both organisational development 
and project management (Fleming et al., 2008). The model allows flow 
between steps, allowing for the collection of information as the change agent 
progresses to inform the steps forward and make adjustments retrospectively. 
This takes into consideration that learning occurs during change, allowing the 
lessons learnt to guide the process (Senge, 1997).   
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The HSE Change Model addresses cultural differences between employees 
from different clinical backgrounds, relevant to this project, where this change 
affects clinicians in general medicine, laboratory clinicians and laboratory 
scientists. Complex working relationships are a possible reason for resistance 
(National Institute for Health and Clinical Excellence, 2007). Organisational 
culture cannot be underestimated when planning for change, (Fleming et al., 
2008; Ogbonna & Harris, 1998; Seel, 2000) although there is a lack of well 
designed research to quantify its effect (Parmelli et al., 2011). A disadvantage 
of the HSE Change Model is that it does not lend itself completely to the 
graduated approach to change. However for this project, a graduated 
approach to change would not be feasible.   
 
The HSE Change Model is comprised of four stages: Initiation, Planning, 
Implementation and Mainstreaming. The author will describe each of the 
activities undertaken during each of the stages, Appendix 6. 
 
3.3 The Change Process: Initiation 
 
3.3.1 Preparing to Lead the Change 
 
The change agent commenced work as an SpR in H1, in July 2013. Soon 
after, the author arranged a meeting with the laboratory management team to 
discuss undertaking a change project. Various proposals were discussed. The 
writer chose this change project, the rationalisation of Legionella Urinary 
Antigen (LUA) testing, for a number of reasons. It had approval of the 
laboratory management team giving it credibility, as organisational change 
cannot occur without the permission of those in authority (The Education and 
Scientific Committee of the Irish Society for Quality in Healthcare, 2006). It 
was an area of personal interest for the change agent. The aims and 
objectives were readily decipherable.  Finally, the experience of the change 
agent having worked previously in two other laboratories could be applied in 
constructing the outline for how the change would be implemented.  
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Rationalisation of LUA tests had been on the management agenda for a 
prolonged period of time. Although identified as a potential area for improved 
use of resources and a cost-management target, other items on the agenda 
were higher priority. However a recent increase in the number of false positive 
results highlighted the urgent need for action.  
 
The direct cost of each test from reagents and direct labour can rapidly 
accumulate (Kwok & Jones, 2005; van Walraven & Naylor, 1998). A positive 
result has a higher cost requiring referral to a reference laboratory for 
investigation. Each positive accrues a large indirect cost to the patient by 
delaying the real diagnosis and the exposure to unnecessary antimicrobials. 
There is also a significant indirect cost to the clinician, clinical microbiology 
and Public Health.  
 
Leading the change the author used various tools. To evaluate the scope of 
the project the aims and objectives were determined as discussed in the 
chapter 1, and agreed with the project sponsor. The change agent proposed 
that a reduction in processing of 20% could be achieved with a combination of 
educational and administrative interventions. This estimate was based on the 
hypothesis that the rate of Pneumococcal Urinary Antigen positivity is 10% 
and that the clinical education would reduce orders by a further 10%. A Mini 
Gantt chart was completed, Appendix 7, to ensure objectives had targeted 
dates for completion and also agreed with the project sponsor. These tools 
held the change agent accountable for the project and allowed planning for 
interventions to be made in advance.  
 
Many tools from the HSEland support website (“HSE First Time Managers 
Programme,” n.d.) prompt the change agent to analyse the trajectory of the 
change prior to its implementation. Identification of the urgency for change 
gives the change the momentum to get started, engage participants (Kotter, 
1995) and continue on a successful path, Appendix 8. A “Stakeholder 
Analysis”, Appendix 9, concentrates the efforts of the change agent into areas 
where amplified communication to create followership are best directed 
(Egan, 1994). The stakeholder analysis presented in Appendix 9, was 
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undertaken at the start of the project. This is an assessment of stakeholders 
as seen in a moment in time. The interest and influence of stakeholders 
fluctuates throughout the change period (Freeman, 2010). Change in complex 
organisations may fail if there is a lack of communication with stakeholders 
and recognition of personal relationships (Karp & Helgø, 2009). The 
stakeholder analysis will be discussed in greater detail in the “Building 
Commitment” stage. 
 
A key step in the initiation stage was the undertaking of an audit. This audit 
was to test the hypothesis that some LUA tests are ordered without indication, 
when compared to the BTS guidelines on the management CAP, Appendix 1 
(Lim et al., 2009). This audit also reviews practice of laboratory staff in the 
processing of LUA test requests when compared to the pre-change SOP and 
guided the development of the SOP.  
 
Completion of a SWOT tool for early identification of risks or issues is 
important preparation for the task ahead, Appendix 10. The pre-change audit 
results provided an excellent platform from which to gain support and 
establish urgency and this strength was used to gain commitment from 
stakeholder groups across interest levels. The perceived lack of interest from 
the NCHD/Clinician group was identified early as a threat through this tool. 
For this reason, engagement with this group was “framed” appropriately, 
highlighting the benefits of change for them as a group (Conger, 1999; Gill, 
2011) as will be discussed later. Through the SWOT it was acknowledged that 
communication with clinicians in three external sites would be difficult. Initially 
it was planned that the change agent would speak in two of the four sites 
however this was later revised and a change agent spoke in one of the sites 
instead, adopting a change champion to speak in a second. 
 
Formal tools exist to assess the readiness for change (Armenakis & Harris, 
2002; Palmer, 2004) within an organisation. The change agent in this project 
informally assessed this readiness in the laboratory, by gauging through 
conversation how change had been received on previous occasions (Smith, 
2005). As previously mentioned, the microbiology laboratory was frequently 
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involved in the adoption and incorporation of new technologies into the 
laboratory. In other areas, such as amongst clinicians, the readiness for 
change was not assessed. Although tools exist to assess the organisational 
culture (Konteh et al., 2008), these were not utilised. Recognition of 
organisational culture and its influence on change is acknowledged 
intrinsically within the HSE Change Model (Fleming et al., 2008). 
 
3.4 The Change Process: Planning  
3.4.1 Building commitment   
The change agent has no formal authority over any of the stakeholder groups 
therefore commitment to the change had to be earned. Leadership can come 
from those outside designated management roles (Karp & Helgø, 2008) and 
emerging clinical leaders are increasingly recognised as a means of quality 
improvement in healthcare (NHS Leadership Academy, 2011; The King’s 
Fund, 2011). Communication with key groups, many of whom were identified 
in the stakeholder analysis, Appendix 9, enables creation of a shared vision 
and fostering of commitment. The importance of communication in any 
change is indisputable, however it is in the planning stage that investment into 
consultation will have the highest return. Communication styles and methods 
were tailored to the target stakeholder groups, with a priority and higher return 
achieved from face-to-face interventions. This was to be expected from the 
literature of change management.  
 
The key groups from whom commitment was required are discussed in this 
section. Many of these groups were outlined in the initial stakeholder analysis. 
A stakeholder analysis can localise areas from where resistance might occur. 
Determining areas of resistance prior to commencing upon a change reduces 
obstacles at a later date. Resistance to change is inevitable (Coghlan, 1993; 
Scott & Jaffe, 1988). Informal discussions at a ward or laboratory level, as 
well as formal meetings with key stakeholders are informative and invaluable 
(National Institute for Health and Clinical Excellence, 2007). These informal 
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interactions with NCHDs (Non- Consultant Hospital Doctors) and laboratory 
scientists consistently occurred throughout the four stages paving the way for 
the change agent to approach things in the larger forums without opposition. 
Distant leadership, as achieved by phone or email, aimed to build 
commitment with stakeholders in the absence of face-to-face engagement. 
 
The audit data was used as a key leverage point with all the key stakeholder 
groups when building commitment. To those stakeholders with high or 
medium level interest it intensified the urgency for change and dissatisfaction 
with the status quo (Fleming et al., 2008; Kotter, 1996). With the stakeholder 
groups whose interest was low, such as the NCHDs, the audit results were 
used as part of the education for raising interest and explaining the rational for 
change.  
 
The laboratory scientists are a key stakeholder group with a variable level of 
interest into the change. Rationalisation of testing and avoidance of 
processing of tests that are not indicated fits with the ideology of laboratory 
scientists. Commitment was gained from this stakeholder group through 
formal and informal communication. Prior to the change being discussed at a 
formal meeting, much of the commitment was elucidated informally over 
coffee.  
 
A formal presentation of the proposed change was made as part of an 
educational talk on Legionnaires’ disease to the laboratory scientists. At this 
stage, the findings of the pre-change audit were presented to the department 
formally, demonstrating that 62.2% of tests were not indicated, the need for 
change was galvanised. This was reflected in many of the laboratory 
scientists approaching the change agent to begin implementation earlier than 
scheduled. Feedback on the proposed changes to the Standard Operating 
Procedure (SOP) was requested at this time. By requesting input from these 
stakeholders, it was hoped that ownership of the change would ensue and 
followership would be strengthened. As any change has a period of transition, 
and processing time will temporarily be increased, some level of resistance 
can be anticipated. This was acknowledged openly in the presentation to the 
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laboratory scientists but highlighted that this period of flux was predicted to be 
short. 
 
The key activity to build commitment from clinicians was a “Grand Rounds” 
presentation, a weekly lunchtime educational meeting well attended by 
NCHDs and Consultants. This Grand Rounds occurred in H1, where the 
change agent is based. Clinicians are a diverse group, made up of both 
NCHDs working in the region for a finite period of time, and Consultants, in 
permanent posts. The clinicians have low interest but high power as they 
request the tests. The leadership challenge then is to engage this group, as 
their support of the project will impact its success. Transformational leaders 
engage followers by using the values of followers.  
 
During Grand Rounds the change agent discussed Legionnaires’, the BTS 
Guidelines for use of a LUA test as well as the impending change. The 
benefits of rationalisation were highlighted such as avoidance of false-positive 
results and improved turn-around time on other tests due to increased and/or 
redistributed resources. To the NCHDs, who rotate through jobs frequently, 
improving turnaround time on specimens is appealing (Wu, 1998). Discussing 
information on organisational cost-saving will appeal to Consultants in 
permanent positions. Clinicians also believe in “Primum non nocere”2 
therefore avoidance of false-positive results is an important value. As will be 
discussed in chapter 5, “framing” of the benefits for change is an important 
method of earning followers (Conger, 1999). The proposed change was 
framed in this way to gain commitment from both parties. Following the 
presentation there was verbal positive feedback, which indicated both 
engagement and a readiness for change.  
 
Initially the respiratory physicians were considered within the same 
stakeholder group as the other physicians, Appendix 9. However, given their 
knowledge of Legionnaires’, they are recognised by all clinicians to have 
expertise, making them opinion leaders and an influential stakeholder group in                                                         2 Primum non nocere – First do no harm, Hippocratic Oath 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their own right. This increases their value as supporters of the change (Kotter, 
1995). The use of guidelines developed by respiratory physicians within the 
BTS as the gold standard for LUA testing gives credence to the project with 
respiratory physicians fostering the adoption of a shared vision. In an effort to 
build commitment with this stakeholder group, the respiratory consultant was 
contacted via email six weeks prior to the implementation of the change to 
inform regarding the change and offer an opportunity to meet to discuss the 
change proposal.  
 
Initially it had been planned that the change agent would undertake a face-to-
face intervention in half of the hospitals (i.e. 2) but this was not undertaken 
due to work constraints and unforeseen circumstances. Therefore in Hospital 
3 (H3), a member of the clinical microbiology team, as a change champion, 
gave an educational talk that included a discussion regarding the appropriate 
use of the LUA test.  
 
The change agent, with one clinical microbiology colleague, further attempted 
to build commitment amongst NCHDs in all four hospitals using opportunistic 
discussion on the appropriate use of the LUA test when consulted as part of 
routine clinical work. However the value of this is difficult to quantify, and as 
an intervention was largely dictated by time constraints. This means of 
communication and leadership is becoming more topical as remote leadership 
is increasingly more called upon with the formation of hospital groups.  
 
A memo was written by the change agent and co-signed by the laboratory 
management team. The intention was that this email would be cascaded to all 
users, via the general manager, in each of the four hospitals. However, as will 
be discussed, it was recognised following the re-audit that the email was only 
received by NCHDs in one of four hospitals, Hospital 2 (H2).  
 
Laboratory management supported the proposal as a quality improvement 
tool and a potential cost-saving means. The change agent met regularly with 
laboratory management to keep the team updated and obtain authorisation to 
proceed as demonstrated in the mini-Gannt chart, Appendix 7. 
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3.4.2 Determining the detail of the change 
 
The SOP was developed by the author using available evidence, clinical 
practice guidelines (Health Protection Agency, 2012; Lim et al., 2009; Mandell 
et al., 2009), and information gathered from the initial audit as well as 
feedback from stakeholder groups, Appendix 3. This proposed SOP was 
presented to key stakeholders for feedback. Laboratory Management 
approved the final SOP prior to implementation.  
 
The planned changes to the SOP were presented to the clinicians at Grand 
Rounds and feedback requested. Two key messages were emphasised to the 
clinicians at this stage.  
• LUA tests should only be requested in accordance with BTS guidelines 
(Lim et al., 2009) and education was delivered around this point.  
• Only forms with relevant clinical information would be processed. Tests 
with insufficient information would not be processed but that the 
specimen would be stored for seven days. If required by the clinical 
team to be processed, the relevant clinical information could be 
provided on repeat form.  
Clinicians present, including representatives from the respiratory department, 
agreed with this proposal. Support from senior clinicians can lead to changed 
behaviour in more junior staff (Dawson et al., 1999) This information was in 
the memo as emailed to H2.  
 
The proposed changes to the SOP were presented to the laboratory scientists 
at the education and information session. This was an interactive session to 
gauge both the level of readiness for change by the laboratory staff and also 
to assess if they were comfortable with the proposed algorithm. It was 
ascertained that the amount of additional educational material as provided by 
the new SOP was sufficient. The change agent arranged that queries on LUA 
test requests could be raised on the daily laboratory round. Empowering the 
laboratory scientists to make decisions with the option of the support of the 
Clinical Microbiology team if required should prevent delays in processing 
from occurring.  
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In accordance with the Employees (Provision of Information and Consultation) 
Act 2006 (House of the Oireachtas, 2006), the change agent invited feedback 
from a number of stakeholder groups, for example at Grand Rounds, at the 
laboratory scientist education session and from laboratory management as 
well as in an email to the Respiratory Consultant.  
 
3.4.3 Developing the Implementation Plan 
 
The finalised laboratory SOP was given to the laboratory Quality Officer to 
allow specific codes be added to the laboratory technology system. A location 
to store the specimens for seven days following receipt was negotiated by the 
change agent once the literature on storing specimens was researched.   
 
3.5 The Change Process: Implementation   
 
The 11th of February 2014 was chosen as the start date for implementation. 
The emailed memo notification of the change had been sent previous to this 
date, although it later became apparent that three of the four hospitals did not 
receive it. Early in the implementation phase, the change agent was available 
for any queries, informally met with the laboratory scientists involved and was 
on hand to deal with issues. Highlighted in the HSE Change Model is the 
need to balance stability and change (Fleming et al., 2008) and for this reason 
the leader felt it was important to be highly visible through this period of 
transition.  During the initial implementation phase, the change agent 
randomly checked at least one request per day from any hospital to determine 
if tests were being processed and/or held appropriately. Subsequently a 
formal post-change audit was undertaken of requests from H1, similar to the 
audit completed in the initiation stage. The change agent put these 
mechanisms in place to avoid a negative impact on service users. As the 
change agent was known to be the key contact for the project, clinicians, 
laboratory scientists and members of the clinical microbiology team channeled 
enquiries directly to them.  
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An issue that arose during the implementation phase, which had not been 
considered in the planning stage, was the appropriateness of amending 
reports. The Irish National Accreditation Board (INAB) is the accreditation 
body for the laboratory of the change agent. Once a report has been 
authorised and available for viewing by the clinical staff it should not be 
altered. As part of this change, the result was authorised as “Not Tested”, 
then if further clinical information was received it was de-authorised and the 
result inserted for re-authorisation. This is incorrect from an accreditation 
viewpoint and a solution was presented by the change agent to the laboratory 
management team. This issue highlights how beneficial auditing of the project 
is in the early stages, as this issue was addressed in real time. It also 
highlights that the senior level support is key in order to rectify issues in real-
time. When a solution to the aforementioned problem was reached, the 
change agent redrafted the SOP and held a short intervention with the 
relevant laboratory staff.  
 
3.6 The Change Process: Mainstreaming 
 
3.6.1 Making it “the way we do business”, Evaluating and Learning 
 
The change agent re-audited four weeks of data following implementation of 
the change, the results of which are presented and discussed in the chapter 
entitled “Evaluation”.  The concept of auditing and re-auditing is lauded in the 
literature (Deming, 1982; Fleming et al., 2008; Langley et al., 2009) as a 
method for continual improvement, Appendix 12. A further benefit is to 
demonstrate improvements, as if gains are not publicised, resisting forces 
could brand the initiative as a failure (Fleming et al., 2008).  
 
The audit results demonstrated both the positive improvements attained to 
date and areas to be targeted for improvements in the future. Presentation of 
improvements and positive feedback will encourage stakeholders to continue 
adherence to the change until it becomes routine (Bareford & Hayling, 1990; 
Dowling, 1988; Nardella et al., 1994). As also highlighted in the literature 
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review, to encourage continued guideline compliance, feedback is required on 
an ongoing basis (Jamtvedt et al., 2006; Mandelblatt & Kanetsky, 1995). 
Improvements to date were presented to the clinicians in H1 via a poster 
presentation at a regional Quality Conference. The change agent hopes to 
present at a local audit meeting scheduled in the near future. A meeting was 
held with the laboratory staff to feedback both the gains as well as potential 
areas for improvement. Audit results were fed back to the Clinical 
Microbiology and laboratory management team at a departmental audit 
meeting.  
 
In future, the indications for requesting a LUA test will be included in the 
introductory NCHD talk that is scheduled biannually in the four hospitals. This 
should target one of the main organisational barriers for change, NCHD 
turnover (Brand et al., 2005). New departmental staff, either to the clinical 
microbiology or laboratory scientist team, receives laboratory training, 
including introduction of the SOPs. It is hoped that further audit cycles will be 
undertaken by a member of the clinical microbiology team in order to maintain 
improvements.  
 
3.7 Conclusion 
 
In conclusion, the change agent, following a review of three change models, 
chose the HSE Change Model for implementation. The main reasons for this 
were its development specifically for use in the HSE, its acknowledgement of 
the role of culture and stakeholders in an organisation as well as its 
comprehensive literature and support documentation to steer the more 
inexperienced change agent. 
 
In the planning stages tools such as a Gannt chart, Stakeholder Analysis and 
SWOT analyses were undertaken. The audit results became a key leverage 
point and influential in the success of the project overall. The planning stage 
involved a significant amount of communication and interaction with 
stakeholder groups.  
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The implementation phase was largely successful however did reveal one 
obstacle but demonstrated the importance of auditing as change is 
implemented as well as the value of laboratory management support. The 
final stage of mainstreaming was achieved by distributing audit results to key 
stakeholder encouraging ongoing support of the change as well as improving 
on gains already achieved.  
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4.0 Evaluation 
 
 
4.1 Introduction 
 
This evaluation chapter looks at tangible outcomes to demonstrate change 
and improvements. Kaplan and Norton, in the discussion on quality 
improvement, state that measurements help to “translate complex and 
frequently nebulous concepts into a more precise form”. Ultimately it is the 
measurements that demonstrate to the organisation and stakeholders, in a 
concrete fashion, what has been changed or improved (Kaplan & Norton, 
1996). Lloyd (2004) highlights the importance of choosing the correct 
indicators to quantify the concept that is being captured, then using this data 
for further interventions as “data without a context for action are useless” 
(Lloyd, 2004).  
 
This chapter will discuss the results of the pre-change audit undertaken in the 
Initiation stage. Subsequently the results of the post-change audit will be 
analysed and discussed. Detailed evaluation will demonstrate if change 
occurred, and if so which interventions or combination of interventions were 
successful. Evaluation post the implementation of change with feedback to 
stakeholders is a key stage in mainstreaming change (Fleming et al., 2008). 
The financial impact of this change will also be critiqued.  
 
Clinical audit is a recognised quality improvement tool, which compares actual 
practice with a guideline. The guideline is usually an accepted standard of 
care or else derived from evidence-based practice. Clinical audit has been 
shown to improve outcomes (Englert, Davis, & Koch, 2001; Lagerløv, Loeb, 
Andrew, & Hjortdahl, 2000) when the information is acted on appropriately, 
Appendix 12.  
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4.2 Pre-change audit 
 
4.2.1 Purpose of pre-change audit 
 
As part of the Initiation stage an audit was undertaken to serve a number of 
purposes. It confirmed a scope to improve practice when compared to local 
and international guidelines. It highlighted areas to be targeted for 
improvement, namely clinician education on when a test is indicated as well 
aiding the development of a laboratory intervention to allow screening of LUA 
test requests. Finally, the audit results highlighted the need for change, 
created urgency and indicated the potential for false-positives when the test is 
processed without indication. The audit results were then used as leverage 
with key stakeholders.  
 
4.2.2 Pre-Change Audit Results 
 
The initial audit was undertaken in H1, where the change agent is based. A 
retrospective review of medical charts, test request forms and clinical 
microbiology notes was undertaken of all LUA test requests in February 2013, 
a 28-day period. 51 tests were requested in 45 patients during the audit 
period and 47 were processed. In 10 tests data were unavailable.  
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Figure: 1 Pre-change Audit 
*47 tests requested – 10 tests (data not available) = 37 tests 
 
37* tests 
Indicated (14)   14  37.8% 
Not indicated: 
Clinical prac<ce (19) 
8 ‐ no pneumonia  21.6% 
4 ‐ CURB65= 0‐1  10.8% 
7 ‐ CURB65= 2  18.9% 
Not indicated: 
Laboratory 
prac<ce(4) 
2 duplicated  5.4% 
1 test not ordered  2.7% 
1 PUA +ve  2.7% 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The ordering behaviour of clinicians was analysed. 8 patients did meet the 
definition of pneumonia3 (21.6%). Of note, the two false-positive results were 
in one patient without pneumonia, therefore the LUA test was not indicated. 
These were deemed to be falsely positive following review of the clinical 
presentation and the Reference Laboratory result. Four patients (10.8%) had 
a CURB-65 score of 0 or 1, which does not require LUA testing as per 
guidelines. Seven patients (18.9%) had a CURB-65 score of 2 without risks 
for Legionnaires’ therefore the test was not indicated (18.9%).  
 
A review of the laboratory process demonstrated that of the tests ordered, two 
duplicated requests were processed for a second time in 48 hours. On 
another occasion, a pneumococcal urinary antigen test was requested 
however a LUA test was performed. One patient had a positive 
Pneumococcal Urinary Antigen therefore it is likely that the cause of their 
pneumonia was Streptococcus pneumoniae and not Legionella pneumophilia. 
 
Of 37 tests audited, 51.3% of tests were not indicated from a clinician ordering 
perspective. 10.8% of tests could have been rationalised from a laboratory 
perspective. In conclusion, 23 (62.2%) of tests processed were not indicated. 
These audit results were used to guide interventions to achieve the aim of this 
project.  
 
4.2.2 Pre-Change Audit Finance 
 
This pre-change audit confirmed that 62.2% of LUA tests that were processed 
were not indicated. This amounts to €18.065.93 due to the cost of each test 
(extrapolated from previous year’s data), and 197 hours of laboratory scientist 
time per annum. This is a conservative estimate that does not include the 
indirect costs as incurred by the false-positive result.  
 
                                                        3 Pneumonia is defined by either the clinical or radiological features consistent with infection 
of the respiratory tract.  
  36 
4.3 Interventions 
 
The process of change is discussed in greater detail in Chapter 3 and 5. The 
first objective was to change the ordering practices of clinicians by education 
on indications for LUA testing. Educational sessions were held in H1 and H3. 
A memo, drafted by the change agent and co-signed by the laboratory 
management team, was distributed in H3. The pre-change audit results were 
used as part of these interventions to create urgency for change and 
demonstrate scope for improvement.  
 
The second objective was to develop a SOP that would enable the laboratory 
scientists to screen requests based on the clinical information provided on the 
form. The audit results were used to create the SOP and were also used in 
the educational presentation to the laboratory scientists. The third objective 
was the rationalisation of LUA testing to reduce costs.  
 
4.4 Post-change Audit  
4.4.1 Post-change Audit Results 
 
The writer re-audited in H1 to capture evidence of changes and improvements 
following the aforementioned interventions. 42 LUA tests were requested in a 
similar study period, in 36 patients. Of these 42 tests requested, 15 (35%) 
were processed. In 5 tests data were unavailable; therefore the data from 37 
tests are presented in Figure 2. 
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Figure 2: Post-change Audit: All orders  
*42 tests requested – 5 tests (data not available) = 37 tests 
 
 
Of the 15 tests that were processed, it was found that when auditing against 
BTS guidelines and the SOP, 9 tests were indicated (60%), Figure 3. Two 
forms had sufficient clinical information and twelve were processed as 
identified as Intensive Care, Haematology or Oncology patients, and met the 
clinical definition of pneumonia. The remaining test was initially not 
processed, however was subsequently processed following the provision of 
information by the change agent, as will be discussed later.  
 
37* tests 
15 processed  
14 processed 
1 processed 
following receipt of 
clinical details 
22 not processed 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Of the 6 tests that were felt to be not indicated from the audit, 2 tests (13.3% 
of those processed) were performed in patients who did not have pneumonia 
but were processed, as the patients were in the Intensive Care Unit, as per 
the SOP, Appendix 3. Two were duplications and 1 had a positive 
pneumococcal urinary antigen test. One test was misidentified as a 
haematology patient by ward, but the admitting consultant was a general 
physician. In conclusion, of the 15 tests processed, 4 tests did not meet the 
criteria for processing at a laboratory level, and 2 did not fit the clinical criteria 
for requesting the test.  
 
 
Figure 3: Post-Change Audit – Analysis of tests processed 
 
This audit included a review of the tests that were not processed, Figure 4. 
This is to determine firstly, if there is an impact on patient care and secondly, 
15 tests processed 
9 indicated   60% 
6 not indicated 
(40%) 
Clinical pracFce  2 = no pneumonia  13.3% 
Laboratory 
pracFce 
2 = duplicaFons   13.3% 
1 = PUA posiFve  6.7% 
1 = misidenFﬁed 
as Oncology 
6.7% 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that the laboratory SOP is being adhered to and tests not meeting the criteria 
for processing are being held appropriately.  
 
Twenty-three tests were initially not processed. As will be discussed, 1 of 
these tests was subsequently processed and found to be negative when 
clinical details on the patient were provided by the change agent. Of the 22 
that were not processed, none of these were indicated as per BTS guidelines 
or the SOP. Fourteen (60.8%) were in patients who did not meet the definition 
of pneumonia, 4 patients had a CURB-65 score of 0 or 1 (17.4%) and in 2 
(8.7%) patients the CURB-65 score was calculated at 2 with no identifiable 
risk of Legionnaires’ upon review of the medical notes. To review laboratory 
practice against the SOP, 2 tests (8.7%) were correctly not tested, as they 
were duplicated specimens.  
 
 
 
Figure 4: Post-change Audit – Analysis of tests NOT processed 
*initially not processed, however was subsequently undertaken following receipt of clinical 
information 
 
23 not processed 
1* indicated 
(4.3%) 
CURB65 Score 2 
with features of 
Legionnaires' 
4.3% 
22 not indicated 
(95.7%) 
Clinical pracFce 
14 = no 
pneumonia 
60.8% 
4 = CURB65 Score 
of 0/1 
17.4% 
2 = CURB65 Score 
of 2 
8.7% 
Laboratory 
pracFce 
2 = duplicaFons  8.7% 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In conclusion, of the 15 tests processed, if the clinical practice guidelines for 
ordering were adhered to and the SOP was followed more prescriptively, a 
further reduction in processing could be made, representing 40% of tests 
ordered. Furthermore, only one of the 23 tests initially not processed did meet 
the clinical criteria for testing but these details were not provided on the form 
as will be discussed. 
 
To look at the data in the context of the objectives, a further analysis of the 
data from all four hospitals in February 2014 was undertaken. The first 
objective was the education of clinicians on the appropriate indications for 
LUA testing. This objective would be measured as reflected in the reduction of 
requests overall, Figure 5. In H1 there was a reduction in ordering from 51 to 
42, representing a 17.6% decrease in ordering. There was a marginal 
increase in order numbers from 21 to 22 in H2 (7%). H3 showed a decrease 
in ordering from 26 to 22 (15%) and in H4 there was a large increase of test 
requests of 60%, from 30 to 48. Overall, unfortunately there was an increase 
in the total number of tests requested from 128 to 131 (2.3%).  
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 Figure 5: Changes in LUA tests requested 
 
The second objective was the development and introduction of a new 
laboratory SOP to allow screening of LUA test requests. The data were 
analysed to demonstrate a reduction in the number of tests processed, Figure 
6. In H1, processing decreased by 68.8%. In H2, the decrease was 81%. In 
H3, the number of tests processed fell by 75% and in H4 it fell by 66.6%. 
Overall, despite the slight increase overall in test requests, the number of 
processed tests fell by 71.5%, from 123 to 35.  
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 Figure 6: Changes in LUA tests processed 
 
4.4.2 Post-change Audit Finance 
 
The third objective was to use the rationalisation of LUA testing as a cost 
improvement process. To translate the above data into cost, 96 tests were 
held without processing. This is a direct reduction in cost of €2,195.52, for a 
28 day period. These tests would have taken one laboratory scientist 24 hours 
to process. In a year, this would suggest a cost saving of €28,541.76 and 312 
laboratory scientist hours.  
 
4.4.3 Survey of NCHDs re Written Intervention  
 
Sixteen randomly selected NCHDs from all four hospitals were surveyed. In 
H1, H3 and H4, none of the 12 NCHDs (4 NCHDs per hospital) surveyed 
reported having received the emailed memo. In H2, of the 4 NCHDs 
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surveyed, three reported receiving the memo. In conclusion it is likely that 
only NCHDs in H2 received the emailed notification. 
 
4.5 Critical Analysis   
4.5.1 Achieving objectives 
 
The first objective was the education of clinicians on the appropriate ordering 
of the LUA test to reduce the number of tests requested, Figure 5, In H1, 
where the change agent undertook a face-to-face intervention, 42 tests were 
requested compared with 51 tests prior to the change, a reduction of 17.6%.  
In H3 where a change champion undertook a face-to-face intervention there 
was a reduction of 15%. Analysis of the data from other hospitals shows 
varied results. In H2 where no face-to-face intervention occurred, but most 
clinicians received written notification of the change by email, there was an 
increase in ordering from 21 to 22 (7%). In H4, where no intervention occurred 
there was a significant increase of 60%.  
 
As discussed in the literature review, face-to-face education is most likely to 
increase guideline compliance and moderate ordering behaviours (O’Brien et 
al., 2007; Soumerai et al., 1993) and this has been demonstrated here. 
Further literature suggests that written interventions alone can increase 
guideline compliance (Giguère et al., 2012), and if the results of H4 are a 
guide, it can be inferred that the memo did have some impact by reducing a 
large increase in orders. Overall across four hospitals there was an increase 
of 2.3%. There is a general increase in laboratory testing of all types year on 
year, however the objective was to reduce LUA test ordering overall which 
was not achieved. 
 
The second objective was a reduction in the number of tests processed. The 
data in this area was favourable overall. Across the region, 131 tests were 
requested, 96 (73.3%) of which were not processed. In two cases, the test 
was processed following the receipt of further clinical details from either the 
clinical team or the change agent. No negative feedback was received from 
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any clinician when a test was held without processing. As seen in Figure 6, 
this decrease in test processing was across all four hospitals. There was a 
decrease in processing of 71.5% comparing the pre-change to post-change 
data. This demonstrates this objective was achieved.  
 
The third objective was to reduce costs through rationalisation of LUA testing. 
Despite an increase in orders overall, given the 71.5% reduction in tests 
processed, a significant cost saving of €2,195.52 and 24 laboratory scientist 
hours was achieved. 
 
The change agent had proposed at the start of the project that a reduction in 
processing of 20% could be achieved with a combination of educational and 
administrative interventions. The literature review suggested that this 
combination of interventions could reduce processing by 50% (Grimshaw & 
Russell, 1994). The reduction in the processing of tests by 71.5% surpassed 
expectations. It is worth noting, that the administrative component of this 
change project was the more successful arm. The use of educational 
techniques alone would have decreased the tests processed in H1 and H2 by 
17.6% and 15% respectively but overall the number of tests processed would 
have increased.  
 
4.5.2 Comparison of audit data 
 
The pre-change audit was a retrospective audit and the month of February in 
2013 was chosen as to coincide with a planned post-change audit in February 
2014. Ideally the same time of year should be audited as Legionnaires’ as 
well as all-cause pneumonia varies by season. There is also a seasonal 
variation in hospital activity levels in general. The post change audit was a 28-
day period from the 11th of February to the 10th of March 2014. Although a 
slight difference in the audit periods of 11 days exists they are still within the 
same season.  
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In the audit period in 2014, there was a seasonal Influenza outbreak locally 
and nationally (Health Protection Surveillance Centre, 2014), when compared 
to the same period of time in 2013, Appendix 15. This likely increased 
admissions of patients with respiratory tract infections with an increase in the 
number of investigations for pneumonia. This may partially explain the large 
increase in test requests in H4.  
 
4.5.3 Retrospective verses real-time audit 
 
The initial audit undertaken was a retrospective audit however the post-
change audit data was collected in real time. When the post-change audit 
commenced, the change agent decided that the collection of data via a chart 
review would enable the change agent to both closely monitor for issues 
arising, as well collect the data with speed. On one occasion, the change 
agent felt, on balance following review of the clinical notes, that a LUA test 
was indicated however was not processed due to insufficient clinical details as 
per the SOP. In the interest of patient safety, the change agent supplied the 
clinical details to the laboratory and the test was processed and was negative. 
The change agent contacted the clinical team and explained what had 
occurred. This opportunity was taken to educate the clinician on the 
importance of provision of the clinical details to avoid a delay to diagnosis or 
compromise of patient care.  
 
4.5.4 Maintaining and Improving on Gains Achieved  
 
Repeated audit cycles with feedback maintains the gains made (Dowling, 
1988). The post-change audit results demonstrate that further improvements 
can be made. Going forward, the value of face-to-face will be utilised by 
discussing LUA testing at NCHD introductory meetings. Feedback of audit 
results to laboratory staff with clarification of some points on the SOP, can 
improve laboratory practices, e.g. ensuring duplicated specimens are not 
processed.  
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4.5.5 False-positive results 
 
One of the key leverage points for this change project was the occurrence of 
false-positive tests. In the initial audit, one false positive occurred, which was 
deemed falsely positive following clinical review of the patient and Reference 
Laboratory result. Due to the lack of clinical information on the request form, if 
it had been received after the implementation of the change it would not have 
met the criteria for processing.  
 
4.6 Conclusion 
 
This chapter has presented the results from two audits, one prior to the 
implementation of a change and one post. The outcomes, as measured in the 
post-implementation audit were designed to evaluate if the stated objectives 
of the change project were met.  
 
The first objective was to educate clinicians on the indications for LUA testing. 
Education varied across the four hospitals in the region, either a face-to-face 
intervention on indications for LUA testing by a change agent or by a change 
champion, an emailed memo, or no intervention. The data suggested that 
face-to-face intervention changes clinician behaviour on laboratory ordering. 
Written information alone is less effective however may have had a 
moderating effect when compared to the data from the hospital where no 
intervention occurred.   
 
The second objective was to reduce the number of tests processed by 
introducing a new SOP enabling laboratory scientists to hold test with 
insufficient clinical details. This was an effective intervention and resulted in a 
71.5% decrease in tests processed. Only 2 of tests of the 131 tests requested 
over the 28-day period where were processed following the receipt of further 
clinical information.  
 
This project successfully achieved the second objective and was partially 
successful in achieving the first. A number of learning points have arisen from 
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this evaluation and will be debated in the next chapter. The third objective was 
to rationalise cost through this undertaking. The reduction in cost of €2,195.52 
in four weeks as well as 24 laboratory scientist hours is proof of this objective 
being achieved.  
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5.0 Discussion and Conclusion 
 
 
5.1 Introduction 
 
In the previous chapter, the results of the change process were presented.  
This project has used the HSE Change Model to initiate, plan, implement and 
mainstream the change process while using clinical audit as a means of 
evaluation. In this final chapter, some of the finer details of the change 
process will be discussed. Success factors will be highlighted. The author will 
discuss threats and areas for potential improvement. There will be an in-depth 
discussion on the evaluation of the change and the impact of the change upon 
the organisation. Finally, the author will make some recommendations for 
others undertaking similar changes in their organisation. 
 
5.2 Success factors 
 
The change agent can identify three strengths of this project, namely  
i. High level management support 
For successful change, powerful followers are valuable (Kotter, 1995). Often 
identified as a critical success factor in literature, necessity of support from 
those in authority is inarguable (Kotter, 1996). This is relevant not only to 
change in general but is also in the literature pertaining particularly to 
changing clinicians practice when ordering laboratory investigations (Bareford 
& Hayling, 1990; Dowling, 1988; Yeh, 2014). The laboratory management 
team from its conception supported this change project, giving it credibility 
with other stakeholders. As the author does not have authoritative power this 
management support gave legitimacy throughout. The laboratory 
management team have a vested interest in the success of this project as a 
cost rationalisation initiative.  
 
Support from senior clinicians has an important role in changing behaviour of 
more junior staff (Dawson et al., 1999). The verbal support from medical 
consultants at the end of the Grand Rounds educational session was likely 
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critical to the overall successful implementation of the change. This could also 
be extrapolated into the laboratory setting where the senior scientist was 
openly supportive of the change.  
 
ii. Persuasive leverage points 
Any change must be assessed on both merits and place within the 
organisational context (Higgs & Rowland, 2010). The current economical 
climate is accommodating to a cost-rationalisation project. The initial audit 
results were convincing and established a sense of urgency by demonstrating 
a potential saving of €18.065.93 and 197 hours of laboratory scientist time per 
annum. This information was used as a key leverage point when negotiating 
with stakeholders.  
 
The mission statement of the hospital group within which this change is 
undertaken is “Together we will provide quality patient care, delivered by 
skilled and valued staff, through the best use of available resources”. This 
statement is similar to the HSE National Service Plan 2014, where the 
employees are encouraged to maximise efficiencies and maintain quality 
patient services (Health Service Executive, 2014). These ideals are reflected 
in the aim of this change project, which is to improve patient care by 
rationalising use of an unnecessary test, reducing costs at the same time.  
 
A successful leader believes in the change they are striving for and develops 
it into a shared vision (Gill, 2011). Transformational leaders motivate people 
and give them a sense of purpose (Gill, 2011) using leverage points such as 
the aforementioned which in turn encourages them to engage with the vision 
of the leader.  
 
A key activity for change in the HSE Model is to “establish a sense of urgency 
and pace the change” (Fleming et al., 2008). The urgency for change is when 
75% of those in positions of power feel that the status quo is not long 
acceptable (Kotter, 1995). The pre-change audit results highlighted false-
positives and the impact they have on patient care, thus creating 
dissatisfaction with current practice (National Institute for Health and Clinical 
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Excellence, 2007) increasing the desire to change (Burnes, 2004b). This 
unrest is also described in the “Unfreeze” stage of Lewin’s Three Stage Model 
(Lewin, 1947).  
 
iii. Felt readiness for change 
The rationalisation of LUA testing had been on the laboratory management 
agenda for a period of time. The increase in false-positive results prioritised 
this as an area for improvement. Given the awareness that this was relatively 
expensive test, it was identified as an area for cost saving. This combination 
of factors ensured that there was a felt readiness for change from the 
laboratory and clinical microbiology viewpoint.  
 
Although formal tools exist to assess an organisations readiness for change 
(Armenakis & Harris, 2002; Palmer, 2004), it can be informally assessed by 
the change agent. Indicators such as informally interacting with staff that will 
be affected by the change and observing employee behaviours in previous 
changes (Armenakis & Harris, 2002; Smith, 2005) are likely assessed by 
leaders subconsciously. Following the presentation to both clinicians and 
laboratory staff, the change agent was informally approached and offered 
support and positive feedback. From this assessment and lack of overt 
resistance, the change was scheduled to be implemented at the earliest 
possible time.  
 
5.3 Areas for improvement 
 
5.3.1 Communication 
 
To “communicate relentlessly” is one of the “Activities for Change” in the HSE 
Change Model (Fleming et al., 2008), Appendix 16. To create a shared vision 
amongst a large number of stakeholders with a varying degree of interest, 
intensive communication is key. The stakeholder analysis, Appendix 9, 
demonstrates which stakeholder groups require more communication than 
others. The value of high-intensity communication to all stakeholders at the 
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start is cited in much of the literature (Fleming et al., 2008; Kotter, 1995; 
National Institute for Health and Clinical Excellence, 2007) but needs to be 
ongoing to maintain momentum (Fleming et al., 2008; Kotter, 1995).  
 
Throughout this project, efforts were made to communicate the vision, to 
varying degrees of success. The main interventions by the change agent were 
presentations given at Grand Rounds in H1 and to the laboratory scientists 
including members of the laboratory management team.  The change agent 
used these presentations to portray themselves, as the change leader, as a 
positive motivated force behind the change process as authenticity is an 
important concept in leadership (Gill, 2011).  
 
As the literature review demonstrated that a combination of interventions is 
more likely to be successful (Marton, 1985; Smellie, 2012; Solomon, 1998), it 
was hoped that the face-to-face intervention followed by written material 
coupled with the administrative intervention would have the largest impact on 
outcomes. As mentioned in Chapter 3, it was planned that a face-to-face 
intervention would occur in two hospitals, with the memo providing 
supplementary information. In the remaining two hospitals, written information 
would be used alone. It transpired that the memo was only circulated in one 
hospital. The change agent should have followed this up at an early time. This 
oversight resulted in a significant increase in requests from H4 where no 
education had been received. It could also be hypothesized, based on the 
literature review, that a combination of face-to-face and written educational 
material in H1 and H3 could have further reduced requests. 
  
In this thesis, the change, although been undertaken in one laboratory, 
affected four regional hospitals and the clinicians and patients within. For that 
reason, the interventions and communications to various clinicians were 
dictated by feasibility. It was this issue, the difficulty in being able to 
communicate effectively with all users, which became the biggest threat to the 
success of the project. Use of an opinion leader in H3, did have a positive 
impact on clinician test requests, as would be predicted by the literature 
(Flodgren et al., 2011). 
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A successful change agent will adjust communication styles for the target 
audience (Fleming et al., 2008). Informal communication and discussions can 
be as valuable as formal scheduled meetings (National Institute for Health 
and Clinical Excellence, 2007). Much of the interest amongst the laboratory 
scientists was generated over coffee and the felt readiness for change was 
apparent in these conversations (Armenakis & Harris, 2002; R. Smith, 2003). 
One of the easiest ways of capturing the NCHD group was one to one when 
discussing consults however this is often dictated by time constraints and 
difficult to capture in terms of quantitative data.  
 
The key intervention with the clinicians was at the Grand Rounds 
presentation. The concept of “framing” was considered in the development of 
the presentation. Framing aims to achieve support for an idea from the 
audience by demonstrating that the intended outcomes are mutually beneficial 
(Conger, 1999). Clinicians are a homogenous stakeholder group, made up of 
NCHDs working short-term contracts, as well as Consultants who are 
generally on permanent contracts. Tangible benefits that would appeal to both 
groups of clinicians were discussed – increased turn-around-time on other 
specimens, cost saving and avoiding false-positives. Gill (2011) notes that 
often lack of commitment to change can result from a lack of compelling 
evidence to change (Gill, 2011). The presenter incorporated shared beliefs by 
referencing the Mission Statement of the hospital – the delivery of quality 
patient care through the best use of resources. Finally, authenticity has 
become a word much used in reference to leadership (Gill, 2011) and is 
crucial when framing a change proposal to future followers.  
 
5.3.2 Gap in Stakeholder Analysis 
 
A stakeholder analysis was undertaken in the Initiation stage, Appendix 9, to 
recognise areas where amplified communication was required as well as 
potential threats. Identifying the shareholder groups in a focused analysis can 
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concentrate the efforts of the change agent into where the creation of 
followership is best directed (Egan, 1994).  
 
It was at the “building commitment” stage when the change agent realised 
that the respiratory physicians had not been considered as a key stakeholder 
group. Although considered as part of the general clinicians they are experts 
in the area of Legionnaires’, increasing their value as supporters of the 
change (Kotter, 1995). This neglect of this group in the Initiation stage 
resulted in the change agent approaching a high impact group with an 
unknown level of interest in the planning stages. An earlier approach would 
have allowed the change agent to request their support and determine what 
level of input they wished to take on. Changes or improvements are 
dependent on having the key people involved from the beginning (Joss, 1994; 
Kotter, 1995) . Although approached at a later date and no overt resistance 
was met, an earlier approach would have been more appropriate.  
 
In the literature it was discussed that collaboration between laboratory 
medicine and clinicians would be necessary to reduce ordering (Baron et al., 
2013; Wu, 1998) further stressing the fact that the respiratory physicians 
should have been approached earlier for an opinion. Young’s Meta-Model For 
Change was not used in this project as the change agent felt that in laboratory 
medicine in the department in question there is no “pre-change paradigm” as 
feedback is not requested from service users outside the laboratory (Young, 
2009). As a means of both quality improvement and planning for service 
provision, general clinicians should be collaborated with going forward.  
 
5.3.3 Delayed recognition of Organisational Culture 
 
For quality improvement initiatives to be successful organisational culture 
needs to be addressed early in the change process (Joss, 1994). 
Organisational culture has been defined as “shared cognitions, standard 
operating procedures, and unexamined assumptions” (Triandis, 1996). The 
change agent was a new member of staff in the organisation therefore many 
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aspects of the culture were not initially evident. Although the change agent 
from the outset acknowledged this gap, it could have presented a greater 
challenge.  
 
Organisational culture can determine if a change is successful or not (Gill, 
2011; Lakomski, 2001; Sarros et al., 2011). Whereas tools exist to “diagnose” 
or assess a culture (Konteh et al., 2008), often it is experience and astute 
leadership skills that enable someone to recognise hidden values or belief 
systems. In Gill’s leadership model, he refers to this “cultural intelligence” as 
one of the seven multiple intelligences of leadership (Gill, 2011).  
 
Various professionals were involved in this undertaking, from a multitude of 
disciplines with competing priorities. The main disciplines were clinical 
microbiology, regarded as a laboratory speciality, general and laboratory 
scientists. Some of the organisational politics at play are generic across all 
organisations, such as the dissonance in priorities of clinical verses laboratory 
medical specialities, a recognised phenomenon (Baron et al., 2013; Wu, 
1998). It was important to the change agent that they were seen as open to 
feedback from physicians challenging the paradigm that the laboratory was 
enforcing this change and increasing the perceived workload of clinicians.  
 
5.4 Relevance of the Literature Review in this Change  
 
As stated in the introductory chapter, the overarching aim was the 
rationalisation of LUA testing. The primary objectives were to inform and 
educate clinicians on Legionnaires’ disease and appropriate investigations, to 
develop a new SOP to allow laboratory scientists to screen test requests, and 
finally to reduce costs by rationalising testing.  
 
The information gleaned from the literature review guided the change process 
overall. Means to increase guideline compliance by clinicians to change 
ordering behaviours were discussed. The BTS guideline (Lim et al., 2009) 
was chosen as it is internationally recognised and locally advocated (Dawson 
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et al., 1999) as recommended by the literature review. Face-to-face 
educational sessions were likely going to have the greatest impact on change 
(O’Brien et al., 2007; Soumerai et al., 1993), however, due to logistics of 
travel to the other locations it became apparent that the change agent would 
be only able to undertake an educational session in H1. Flodgren et al, 
advocate the use of opinion leaders in increasing guideline compliance and 
this was utilised in H3 (Flodgren et al., 2011) where a change champion gave 
face-to-face education on BTS guideline compliance. This change champion 
has a high level of power in that organisation, and is perceived as 
knowledgeable in the subject matter making them an influential opinion leader 
(Doherty, 2006; National Institute for Health and Clinical Excellence, 2007). 
High level support is critical to any change (Kotter, 1996) and their 
demonstration of support likely contributed to the reduced ordering of LUA 
tests in that hospital.  
 
As can be seen from the evaluation of the change, there was a reduction in 
ordering in the two centres where the face-to-face interventions occurred, with 
a reduction of 17.6% and 15% in H1 and H3 respectively. As predicted by the 
literature review (O’Brien et al., 2007; Soumerai et al., 1993) and now evident 
from practice, face-to-face education increased support for the change more 
than if education was via written information alone (Giguère et al., 2012) or no 
intervention. There are likely to be many contributing factors to these results. 
Direct interaction with a transformational leader is more likely to engage 
followers and enhance compliance to whatever behaviour is being 
encouraged (Hur, van den Berg, & Wilderom, 2011; Kelley, 1997; Menges, 
Walter, Vogel, & Bruch, 2011) evidence for which pertains often to the direct 
personal interaction between leaders and followers (Gibson & Manuel, 2003). 
It is therefore likely that the face-to-face interaction with the change agent 
and/or the change champion contributed to the increase in compliance to the 
guidelines.  
 
However challenges to leadership are ever changing and as discussed in the 
Introductory chapter, leaders of the future, with increasing globalisation, will 
have to be able to lead from a distance, often over teams who they may not 
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have direct authority over (Hay Group, 2011). Transformational leadership 
can still occur from virtual leaders (Gibson & Manuel, 2003; Holtbrügge et al., 
2011), even through the media of email, which as a mode of communication is 
not ideal as it lacks the non-verbal cues of face-to-face interactions (Gibson & 
Manuel, 2003; Kayworth & Leidner, 2000). Overall, it must be stated, that 
although face-to-face interventions are likely increase compliance to change 
and motivate employees, in situations where this is not a possibility, other 
means to engage with change will have to be improved. To challenge the 
organisational barrier to change of NCHD change-over, the NCHD 
introductory meeting will include education on use of the LUA test (Brand et 
al., 2005).  
 
A further aspect of the literature review was investigating available evidence 
on how to rationalise use of a laboratory test. The importance of not 
negatively impacting on patient care as well as not delaying important 
diagnoses when rationalising laboratory testing was highlighted (Cherry, 
2005; Friedman & Katt, 1991). To ensure, as much as possible, that this was 
not the case, the change agent audited in H1 to capture if unprocessed tests 
were indicated or not. It was demonstrated of the 23 tests initially not 
processed one was indicated. As was discussed, this was processed by the 
request of the change agent and was negative.  
 
A key objective of this project was the rationalisation of the LUA test through 
development of a SOP to screen requests. Education combined with audit 
was demonstrated in the literature review to increase clinician guideline 
compliance (Jamtvedt et al., 2006; Mandelblatt & Kanetsky, 1995; Soumerai 
et al., 1993) but also pertinent to rationalising tests (Bareford & Hayling, 1990; 
Nardella et al., 1994; Yeh, 2014). As evidenced by the literature review, 
administrative, educational or a combination of both interventions could be 
used to reduce inappropriate testing (Calderon-Margalit et al., 2005; Marton, 
1985; Smellie, 2012; Solomon, 1998) as utilised in this project. To rationalise 
laboratory testing, senior management support is crucial and was available to 
the change agent from the laboratory management team as evidenced by 
encouragement of the undertaking from the beginning as well as co-signing 
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the memo, and swiftly allowing rectification of the SOP when an issue arose 
(Bareford & Hayling, 1990; Dowling, 1988; Kotter, 1996; Yeh, 2014). As the 
change agent has little power and influence, this public support was a critical 
success factor.  
 
Finally, to rationalise testing, collaboration between laboratory clinicians and 
physicians is advocated (Baron et al., 2013; Wu, 1998). As previously 
discussed in relation to communication, the respiratory physicians should 
have been approached early in the change project to determine if they 
supported the change. Feedback was welcomed from physicians at the 
educational session.  
 
5.5 Potential Threats and Learning Points 
 
5.5.1 Power and Influence 
 
As a Non-Consultant Hospital Doctor, albeit as an SpR, the change agent has 
little power. As a previously unknown character, their influence was low, and 
they carried minimal authority. According to Gill, there are two types of 
change, one imposed from a position of authority, the other participative (Gill, 
2011). The power of the change agent was their authorisation to change the 
laboratory SOP; however had no authority over the laboratory scientists to 
accept the new procedure. The change agent has no power over the 
clinicians ordering the tests, and can then only cause change by generating 
commitment through leadership skills (Grimshaw & Russell, 1994). The NHS 
Leadership Academy, embraces leaders outside formal positions of power 
(NHS Leadership Academy, 2011; The King’s Fund, 2011), recognising that 
positive changes in healthcare often come from front-line staff.  
 
5.5.2 NCHD turnover 
 
Until the new way-of-doing-business becomes engrained in the organisation, 
it is still at risk of failing, which can take a significant period of time, often 
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years (Kotter, 1995).  The high turnover of NCHDs is an example of an 
organisational barrier to change (Bareford & Hayling, 1990; Dowling, 1988). 
That risk in reference to this change initiative is two-fold. Both the change 
agent and many of the clinicians ordering the tests, rotate through posts 
regularly. It is then vital that the change agent ensures high-level stakeholder 
commitment is obtained from permanent staff to ensure the longevity of the 
project. Audit and feedback on both clinician compliance to BTS guidelines in 
ordering tests as well as laboratory scientist compliance with the SOP are 
required on an ongoing basis to maintain improvements (Dowling, 1988). New 
NCHDs as well as new laboratory scientists will receive education on LUA 
testing and the local SOP when commencing in a post. It will be dependent on 
encouragement from the senior clinical microbiology team, that re-auditing will 
be undertaken by subsequent clinical microbiology SpRs.  
 
5.5.3 Collaborative team engagement 
 
With regards to the laboratory scientists in particular, creating an atmosphere 
where a frank discussion on the proposed change can occur is important. 
Clinical microbiology and the laboratory Scientists work together as a team, 
and a team that values contributions from all member is more likely to be 
engaged thus more effective (Borrill et al., 1999; Tanco et al., 2011). 
Collaboration between laboratory clinicians and physicians is also an 
important example of collaborative team approaches to service improvement 
(Baron et al., 2013).  
 
5.5.5 Resistance  
 
Resistance to change is inevitable (Coghlan, 1993; Scott & Jaffe, 1988) and 
can come in many forms, passive or covert, verses open or hostile (Bovey & 
Hede, 2001). The largest source of resistance met was likely from the 
clinicians ordering the LUA tests. Although no open resistance was 
encountered, the ongoing request for LUA tests without indication could 
demonstrate covert resistance. There were some improvements made 
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however there is still considerable room for improvement as 59.5% of the 
tests ordered were not compliant with guidelines. To refer back to the 
literature review, clinicians may not be compliant with guidelines due to lack of 
awareness of the guidelines existence or their lack of agreement with it 
(Cabana et al., 1999). These areas can be targeted in the future, by 
collaboration with clinicians and increasing education prior to re-auditing. 
 
Kotter and Schlesinger describe six different management or leadership 
techniques to address resistance and lead people through the change 
process (Kotter & Schlesinger, 2008) ranging from education to coercion. 
Education is effective, yet often time intensive, but an important tool in any 
change undertaking (Fleming et al., 2008) and used throughout here. Another 
tool, manipulation, can take a varying number of forms, one example of which 
would be the use of a incident to create an urgency or impetus for change 
(Tiernan, Morley, & Foley, 2006), which was what was done when highlighting 
to clinicians that unnecessary testing increases the likelihood of false-positive 
results.  
 
5.6 Impact of the project 
 
5.6.1 Impact on the patient 
 
Although not demonstrable, it is hoped this project improves patient care 
through improved use of resources. No false-positive results occurred during 
the audit period, and it is proposed that if fewer tests are processed 
unnecessarily then rates of false-positive results fall. As no cases of 
Legionnaires’ were diagnosed in the audit period it cannot be assessed if any 
delay to diagnosis occurred.  
 
5.6.2 Impact on clinicians 
 
Clinician’s benefit from improved use of resources by improved turn-around-
time on other samples. Only 2% of tests were processed after initially being 
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held, both of which were negative for Legionnaires’. No negative feedback 
was received on tests not being processed. No false-positive results occurred.  
5.6.3 Impact on laboratory staff 
 
In a service with increasing workloads without an increase in staffing numbers 
(Health Service Executive, 2014), a safe and evidence based reduction of 
unnecessary testing is welcomed. The estimated potential saving of 312 
laboratory scientist hours is a positive outcome.  
 
5.6.4 Impact on the change agent 
 
This is the first large scale change undertaking by the author. The change 
agent put the academic learning from the first year of this Masters Programme 
into practice, with guidance from the action learning skill sets. Implementation 
of a change tests leadership skills. It is informative from a self-development 
viewpoint. The skills and experience gained from this project will be beneficial 
in undertakings in the future, such as the value of really knowing one’s 
stakeholders and the ability to manage resistors. As leaders have recognised 
before, it is not the specific skills or tools learnt that improves one as a leader, 
more it is the recognition that a mind open to learning allowed them to be 
successful the first time around (Quinn, 2011). Improvements were seen 
following this project giving the change agent confidence in future 
undertakings.  
 
5.6.5 Impact of the project on the organisation and beyond 
 
This project is in accordance to the mission statement of the hospital as well 
the HSE National Service Plan (Health Service Executive, 2014) and resulted 
in considerable savings. This project was presented at the local Quality 
Conference to encourage other members of staff to undertake quality 
improvement projects. The initial audit findings were presented at the Irish 
Society for Clinical Microbiology, and it is hoped that the post-change data will 
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be presented at the next meeting, to encourage other laboratories to 
rationalise testing leading to further improvements nationwide. 
 
5.7 Recommendations for future improvements  
 
5.7.1 Face-to-face interventions are key 
 
This project has clearly demonstrated the value of face-to-face engagement 
with followers in both increasing guideline compliance and rationalising 
laboratory testing. The use of an opinion leader in H3 was clearly 
demonstrated and in retrospect, opinion leaders in H2 and H4 may have 
drastically changed results. Where “social-marketing” is not possible and 
outcomes still need to be achieved, the leader needs to be able to engage 
stakeholders through other methods. The distribution of the emailed memo in 
H2 prevented a dramatic increase in ordering but did not rationalise requests. 
In the era of distance management, this mode of communication is an 
important tool and will likely need to be perfected for the future.   
 
5.7.2 Acknowledge key stakeholders from the beginning 
 
Failure to acknowledge the respiratory clinicians as a key stakeholder group 
in their own right was an oversight on behalf of the change agent. Although 
there was no apparent negative impact, involvement of key players from the 
beginning of any change is crucial to sustained success (Fleming et al., 2008; 
Kotter, 1995).  
 
5.7.3 Obtain high-level support  
From the initiation stage, the change agent had the support of the laboratory 
management team. As the change process evolved and different stakeholder 
groups were approached, more high-level support was won and vocalised at 
the Grand Rounds and the laboratory scientist meeting. When issues arose in 
the implementation phase, it was through the swift response of the 
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management team that the change agent was able to resolve the problem 
and continue with the change.  
 
5.7.4 Use leverage points where available   
The value of convincing rationale for change cannot be underestimated. 
Stakeholder groups were won over by the dramatic results of the pre-change 
audit. Many benefits to change were demonstrable and persuasive, and 
frequently referenced in any interactions with stakeholders.   
 
5.8 Conclusion 
 
Each organisation and context is different therefore obstacles that arose 
during this implementation may not be the same as those that occur 
elsewhere. What is valuable from this change experience is the development 
of core skills, such as communication. Going forward, the change agent has 
learnt the ability to learn and adapt to challenges, seeking out the information 
to guide the route forward, which is the most important learning (Quinn, 2011).  
 
Change is a constant reality, particularly in healthcare. The introduction of 
change to improve the quality of patient care delivered is often not easy, 
however as frequently stated; small changes can have a significant positive 
effect (National Institute for Health and Clinical Excellence, 2007). In the 
words of Tony Robbins, “for changes to be of any true value, they’ve got to be 
lasting and consistent” therefore this change has not ended, but can be built 
upon in this organisation, as well as demonstrating to other organisations the 
gains that are possible.  
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